Test
ARRMerger
Overview
Argyle Research is initiating coverage on ARR with an Outperform rating.
The recent merger presents a unique opportunity in the current market environment, primarily driven by:
- Synergies in operational efficiency
- Expanded market reach in EMEA
- Strong free cash flow yield standing at ~8%
Valuation
Our target price of $45.00 is based on a conservative 12x EV/EBITDA multiple applied to our FY26 estimates. For detailed financial modeling, please download the full PDF report below.
"The strategic integration of these two entities is expected to yield unprecedented growth vectors in the next 18-24 months."